ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,548, issued on Feb. 17, was assigned to Sichuan Clover Biopharmaceuticals Inc. (Sichuan, China).
"HIV vaccine compositions, methods, and uses thereof" was invented by Peng Liang (Chengdu Sichuan, China) and Joshua Liang (Chengdu Sichuan, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses immunogenic compositions including recombinant peptides and proteins comprising human immunodeficiency viruses (HIV) antigens and immunogens, e.g., gp 120 protein peptides. In some aspects, the immunogenic composition comprises a secreted fusion protein comprising a soluble HIV viral antigen joined by in-frame fusion to a C-terminal...